MEDISEARCH INTERNATIONAL
0447.598.679 · rovalta.com · 24/09/2026
ACTIVE
MEDISEARCH INTERNATIONAL
Financial year 2024 · Closed on 31/12/2024
Net result
83 €
-65,6 %over 1 yearGross margin
-1,6 k €
+79,5 %over 1 yearEquity
53,3 k €
+0,2 %over 1 yearOverview
Identity
Source · BCE/KBOMEDISEARCH INTERNATIONAL is a Private company with limited liability incorporated in 1992. Its main activity is: Research and experimental development on natural sciences and engineering. Its registered office is in Bree.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0447.598.679
- Incorporation
- 03/06/1992
- Legal form
- Private company with limited liability
- Registered office
- Keyartstraat 28 C
3960 Bree · FlandreSee on map - Contributed capital
- 21 071,00 €
- Latest accounts
- 31/12/2024
Activities (NACE)
72109Research and experimental development on natural sciences and engineering· main72190Other research and experimental development on natural sciences and engineering72101Research and experimental development on natural sciences and engineering72110Research and experimental development on biotechnology73120Media representation73120Media representation+2
Joint committees (2)
- 218
- 330
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflow
Financials
Source · NBB, 19 filingsTrend over 19 financial years
| 2024 | 2023 | 2022 | 2021 | 2020 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | -1,6 k € | +79.5% | -7,9 k € | -215% | 6,9 k € | -43.8% | 12,3 k € | -25.7% | 16,6 k € |
| EBITDA | -2,1 k € | +75.2% | -8,4 k € | -250% | 5,6 k € | -50.3% | 11,2 k € | -22.2% | 14,4 k € |
| Operating result | -2,1 k € | +75.2% | -8,4 k € | -297% | 4,3 k € | +2.1% | 4,2 k € | -45.3% | 7,6 k € |
| Net result | 83 € | -65.6% | 241 € | +137% | -657 € | -228% | 512 € | +194% | 174 € |
| Balance sheet | |||||||||
| Equity | 53,3 k € | +0.2% | 53,2 k € | +0.5% | 52,9 k € | -1.2% | 53,6 k € | +1.0% | 53,1 k € |
| Total assets | 56,5 k € | -1.2% | 57,2 k € | -26.9% | 78,2 k € | -0.3% | 78,5 k € | -9.3% | 86,5 k € |
| Cash | 2,2 k € | -47.4% | 4,2 k € | -43.4% | 7,4 k € | -21.1% | 9,4 k € | -80.7% | 48,7 k € |
| Debts | 3,2 k € | -18.7% | 4 k € | -84.3% | 25,3 k € | +1.7% | 24,9 k € | -25.5% | 33,4 k € |
| Other | |||||||||
| Workforce | – | – | – | – | – | ||||
Valuation
Indicative valuation
As an indication, this company is worth
between 0 € and 100 k€
See the valuationBoard of directors
Source · NBB, accounts to 31/12/20241 active · 5 ended
Active mandates
HANS VERHELST
ActiveEnded mandates
JOS CLAESSENS
EndedJOS CLAESSENS
EndedJOS CLAESSENS
EndedHANS VERHELST
EndedOther companies at this address
Keyartstraat 28 C 3960 Bree| Company | CBE no. |
|---|---|
DR. H. VERHELST● Active | 0860.185.706 |
Financials
Full financial information
Source · NBB| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 | 01/01/2019 |
| Closing of the financial year | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 | 31/12/2019 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 30/09/2025 | 31/12/2024 | 06/10/2023 | 30/12/2022 | 30/11/2021 | 31/01/2021 |
| General meeting | 25/09/2025 | 09/11/2024 | 05/10/2023 | 11/11/2022 | 29/11/2021 | 29/11/2020 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for 7 daysAnnual accounts filings
Source · NBB, 19 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 31/12/2024 | 25/09/2025 | 30/09/2025 | Dutch | |
| Micro model | 31/12/2023 | 09/11/2024 | 31/12/2024 | Dutch | |
| Micro model | 31/12/2022 | 05/10/2023 | 06/10/2023 | Dutch | |
| Micro model | 31/12/2021 | 11/11/2022 | 30/12/2022 | Dutch | |
| Micro model | 31/12/2020 | 29/11/2021 | 30/11/2021 | Dutch | |
| Micro model | 31/12/2019 | 29/11/2020 | 31/01/2021 | Dutch | |
| Micro model | 31/12/2018 | 30/07/2019 | 29/08/2019 | Dutch | |
| Abridged model | 31/12/2017 | 30/06/2018 | 31/08/2018 | Dutch | |
| Abridged model | 31/12/2016 | 30/06/2017 | 31/08/2017 | Dutch | |
| Abridged model | 31/12/2015 | 30/06/2016 | 31/08/2016 | Dutch | |
| Abridged model | 31/12/2014 | 25/06/2015 | 16/07/2015 | Dutch | |
| Abridged model | 31/12/2013 | 13/06/2014 | 30/08/2014 | Dutch | |
| Abridged model | 31/12/2012 | 29/07/2013 | 28/08/2013 | Dutch | |
| Abridged model | 31/12/2011 | 22/10/2012 | 08/11/2012 | Dutch | |
| Abridged model | 31/12/2010 | 31/08/2011 | 31/08/2011 | Dutch | |
| Abridged model | 31/12/2009 | 23/08/2010 | 26/08/2010 | Dutch | |
| Abridged model | 31/12/2008 | 13/10/2009 | 29/10/2009 | Dutch | |
| Abridged model | 31/12/2007 | 15/12/2008 | 30/12/2008 | Dutch | |
| Abridged model | 31/12/2006 | 31/07/2007 | 22/08/2007 | Dutch |
Valuation
Indicative valuation
Order of magnitude
As an indication, this company is worth
between 0 € and 100 k€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20241 active · 5 ended
Active mandates
HANS VERHELST
ActiveEnded mandates
JOS CLAESSENS
EndedJOS CLAESSENS
EndedJOS CLAESSENS
EndedHANS VERHELST
EndedOwnership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette publications
Source · Belgian Official GazetteSimilar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2024Annual accounts 202483 €↓
- 2023Annual accounts 2023241 €↑
- 2022Annual accounts 2022-657 €↓
- 2021Annual accounts 2021512 €↑
- 2020Annual accounts 2020174 €↑
- 2019Annual accounts 201925 €↓
- 2018Annual accounts 201816,4 k €↑
- 2017Annual accounts 2017176 €↑
- 2016Annual accounts 2016-17,3 k €↓
- 2015Annual accounts 20152,1 k €↓
- 2014Annual accounts 201446,1 k €↑
- 2013Annual accounts 2013-1,3 k €↑
- 2012Annual accounts 2012-7,5 k €↑
- 2011Annual accounts 2011-23,4 k €↓
- 2010Annual accounts 2010-883 €↑
- 2009Annual accounts 2009-1,2 k €↓
- 2008Annual accounts 200828,7 k €↑
- 2007Annual accounts 20071,7 k €↑
- 2006Annual accounts 2006-17,1 k €
- 03/06/1992IncorporationPrivate company with limited liability